Peter Soparkar
Geschäftsführer bei ADVERUM BIOTECHNOLOGIES, INC.
Vermögen: 239 628 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Peter Soparkar
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 45 | |
| Public Company | Pharmaceuticals: Major | 38 | |
Myriad Women's Health, Inc.
 Myriad Women's Health, Inc. Medical/Nursing ServicesHealth Services Myriad Women's Health, Inc. provides pre-pregnancy genetic testing services. It operates as a medical technology company that gives people access to vital information about their bodies, including DNA analysis for family preparation, and inherited cancers. The firm offers genetic counseling over the phone and gives client direct access to a professional genetics expert who can interpret their report. The company was founded by Ramji Srinivasan, Eric A. Evans, Rishi Kacker and Balaji S. Srinivasan on October 24, 2007 and is headquartered in South San Francisco, CA.
12
| Subsidiary | Medical/Nursing Services | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter Soparkar
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member General Counsel Investor Relations Contact General Counsel Director/Board Member Chief Tech/Sci/R&D Officer General Counsel Investor Relations Contact Director/Board Member Director/Board Member Human Resources Officer Chief Operating Officer Compliance Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MYRIAD GENETICS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Wisconsin | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Chairman Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
| University College Dublin | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Emergent BioSolutions Ireland Ltd.
 Emergent BioSolutions Ireland Ltd. Pharmaceuticals: MajorHealth Technology Adapt Pharma Ltd. develops and distributes therapeutic treatments. The company was founded by David Brabazon and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer Founder Chief Operating Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of San Francisco | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| Trinity College Dublin | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| San Jose State University | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director of Finance/CFO | |
| Yale University | College/University | Graduate Degree Undergraduate Degree | |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Santa Clara University | College/University | Undergraduate Degree Graduate Degree | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Director/Board Member | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Tecan Genomics, Inc.
 Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Tecan Genomics, Inc. provides genomics sample preparation solutions. It offers solutions which make biological samples accessible for genomic analysis. The firm has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagnostic applications. The company was founded by Jan D'Alvise, James W. Larrick and Nurith Kurn in 2000 and is headquartered in San Carlos, CA. | Electronic Equipment/Instruments | Director/Board Member Director of Finance/CFO | |
AIDS Healthcare Foundation
 AIDS Healthcare Foundation Investment Trusts/Mutual FundsMiscellaneous AIDS Healthcare Foundation is a non-profit organization which engages in the provision of medicine and advocacy programs for HIV/AIDS. The firm offers HIV and STD testing, thrift store, dental clinic, and healthcare center services. The company was founded by Michael Weinstein in 1987 and is headquartered in Los Angeles, CA. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer |
Statistik
International
| Vereinigte Staaten | 42 |
| Irland | 6 |
| Vereinigtes Königreich | 4 |
| Italien | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 17 |
| Finance | 2 |
| Process Industries | 2 |
| Government | 2 |
Operativ
| Director/Board Member | 450 |
| Corporate Officer/Principal | 236 |
| Independent Dir/Board Member | 157 |
| Undergraduate Degree | 85 |
| Chief Tech/Sci/R&D Officer | 78 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Patrick Enright | 41 |
| Thomas Woiwode | 39 |
| James Momtazee | 31 |
| Reed Tuckson | 31 |
| Karen Wilson | 31 |
| Elmar Schnee | 31 |
| Kathryn Falberg | 30 |
| Clarence Machado | 30 |
| Karen Smith | 29 |
| Norbert Riedel | 29 |
| Paul Berns | 28 |
| Catherine Sohn | 27 |
| Jim Scopa | 26 |
| Laurent Fischer | 23 |
| Bryan Geoffrey Morton | 22 |
- Börse
- Insiders
- Peter Soparkar
- Unternehmensverbindungen